tm logo
TEVA & DESIGN
REGISTERED

on 20 Nov 2019

Last Applicant/ Owned by

TEVA PHARMACEUTICAL INDUSTRIES LTD.

124 Dvora HaNevi'a6944020 Tel Aviv-Jaffa

IL

Serial Number

1835942 filed on 04th May 2017

Registration Number

TMA1063768 registered on 20th Nov 2019

Registration expiry Date

20th Nov 2029

Correspondent Address

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

CA

K1P1J9

TEVA & DESIGN

Vienna Information


26 . 4 . 4

Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded cornersAutres parallélogrammes, trapèzes et quadrilatères irréguliers, quadrilatères avec un ou plusieurs coins arrondis

26 . 4 . 9

Several quadrilaterals juxtaposed, joined or intersectingPlusieurs quadrilatères, juxtaposés, accolés ou se coupant

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

24 . 15 . 21

Arrowheads -- Note: Not including arrowheads in the form of angles (26.3.23).Pointes de flèches -- Note: Non compris les pointes de flèches en forme d'angles (26.3.23).

5 . 3 . 11

Other leavesAutres feuilles

5 . 3 . 13

Stylized leavesFeuilles stylisées

5 . 3 . 15

Two to four leavesDeux à quatre feuilles

25 . 5 . 3

Backgrounds divided into two, diagonallyFonds partagés en deux en oblique

26 . 2 . 1

Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 3

Sectors of circles or ellipses (except 26.2.7)Secteurs de cercle ou d'ellipse (excepté 26.2.7)

26 . 2 . 5

Joined or intersecting segments or sectors of circles or ellipsesSegments ou secteurs de cercle ou d'ellipse, accolés ou se coupant

26 . 11 . 2

Two lines or bandsDeux lignes ou bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 4 . 2

RectanglesRectangles

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 12

Quadrilaterals containing one or more other geometrical figures -- Note: Including quadrilaterals containing bent or straight lines (except 26.4.11).Quadrilatères contenant une ou plusieurs autres figures géométriques -- Note: Y compris les quadrilatères contenant des lignes courbées ou droites (excepté 26.4.11).

26 . 1 . 1

CirclesCercles

26 . 1 . 6

Several circles or ellipses, juxtaposed, tangential or intersectingPlusieurs cercles ou ellipses, juxtaposés, tangents ou se coupant

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

29 . 1 . 3

GreenVert

29 . 1 . 6

White, grey, silverBlanc, gris, argent

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

Trademark usage description

pharmaceutical preparations for the prevention and treatment of alzheimer's disease; pharmaceutical preparations for the prevention and treatment of d Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders, namely, Parkinson's disease and spinal muscular atrophy; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders, namely, carpal tunnel syndrome and connective tissue diseases; Pharmaceutical preparations for the prevention and treatment of digestive tract and gastrointestinal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely, dermatitis, eczema and psoriasis; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents for the treatment of the central nervous system, namely, for treating encephalitis, epilepsy, cerebral palsy, multiple sclerosis and Huntington's disease; Pharmaceutical agents for the treatment of circulatory systems, namely, for treating atherosclerosis, aneurysms and Raynaud's disease; Pharmaceutical agents affecting sensory organs, namely, for treating hearing loss and glaucoma; Pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases and incontinence.


Classification kind code

11

Mark Details


Serial Number

1835942

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 28th Feb 2019
Approved
Submitted for opposition 27
on 08th Jan 2019
Approval Notice Sent
Submitted for opposition 87
on 08th Jan 2019
Rep for Service Changed
Submitted for opposition 48
on 08th Jan 2019
Agent Changed
Submitted for opposition 15
on 29th May 2018
Correspondence Created
Submitted for opposition 22
on 20th Apr 2018
Search Recorded
Submitted for opposition 20
on 20th Apr 2018
Examiner's First Report
Submitted for opposition 31
on 10th May 2017
Formalized
Submitted for opposition 1
on 05th May 2017
Created
Submitted for opposition 30
on 04th May 2017
Filed